Latest News and Press Releases

RICHMOND, Va., Sept. 23, 2019 (GLOBE NEWSWIRE) -- ALR Technologies, Inc. (OTCPINK: ALRT) has created an algorithm for advancing medication therapies for patients with non-insulin dependent type 2...

RICHMOND, Va., Sept. 18, 2019 (GLOBE NEWSWIRE) -- ALR Technologies, Inc. (OTCPINK: ALRT) ALRT Diabetes Solution is adding support for continuous glucose monitoring (CGM) systems to the ALRT diabetes...

RICHMOND, Va., April 02, 2019 (GLOBE NEWSWIRE) -- “Clinical inertia causes diabetes to deteriorate in millions of patients,” said Sidney Chan, CEO of ALR Technologies Inc. (OTCPINK: ALRT), the...

ALRT’s comprehensive diabetes management system could improve outcomes and provide diagnostic tools for diabetes therapies in one of the world’s most critical diabetes markets RICHMOND, Va., Oct. ...

ALRT and Aspire Cerebro will collaborate to market ALRT’s comprehensive diabetes management system to Indian pharmaceutical companies and help improve diabetes management RICHMOND, Va., Aug. 27,...

RICHMOND, Va., June 28, 2018 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (OTCPINK:ALRT) will be offering Integrated Solution to health insurance payers to help their clinical teams deliver best...

The ALRT Diabetes Solution is an enterprise-scale product that allows healthcare systems to implement best practices for diabetes care on large populations of patients - saving lives and money. ...

RICHMOND, VA--(Marketwired - October 23, 2017) - Following the recent FDA clearance of the Company's Insulin Dose Adjustment feature and release of its patent pending Predictive A1C innovation, ALR...

RICHMOND, VA--(Marketwired - October 16, 2017) - Following the recent FDA clearance of the Company's Insulin Dose Adjustment feature, ALR Technologies Inc. ("ALRT" or the "Company") is releasing...

RICHMOND, VA--(Marketwired - September 25, 2017) - On September 18, 2017, the United States Food and Drug Administration (FDA) granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an...